Please select a HGH news story from the list below:
August 31, 2007 -- Somatuline([R]) Depot Becomes the First Product Originating from Ipsen's R&D to Be Approved by the FDA and Marketed Globally(1) PARIS --...
August 29, 2007 -- * Increased effort in Research & Development * Results in line with management expectations: full year 2007 operating margin guidance confirmed...
August 9, 2007 -- PARIS -- Regulatory News: Increlex([R]) is the First Recombinant Human Insulin-Like Growth Factor-1 Therapy Approved in Europe for Severe Primary...
August 1, 2007 -- * +7.6% growth in Group sales, +9.3% growth in volume sold * Continued growth outside the Major Western European Countries: +16.2% * Strong...
May 25, 2007 -- PARIS -- Regulatory News: Upon marketing authorization, Increlex([R] )will be commercialized in the European Union by Ipsen, Tercica's partner...
March 19, 2007 -- * Recurring Operating Margin((2)) above Objectives: 23.7% of Net Sales * Strong Increase in Recurring Consolidated Profit((2)): +15.6% * All Time...
October 16, 2006 -- PARIS & BRISBANE, Calif. -- Ipsen (Euronext:IPN) and Tercica, Inc. (Nasdaq:TRCA) today announced the closing of their worldwide strategic...
November 21, 2001 -- Business Editors & Health/Medical Writers CAMBRIDGE, Mass.--(BUSINESS WIRE)--Nov. 21, 2001 Alkermes, Inc. (NASDAQ: ALKS) announced today that its...
brisbane medical writers cambridge paris
Our goal is to spread human growth hormone information in the form of general information and useful HGH articles from a wide variety of print publications.
If we've proved to be a useful resource why not now?
designed: expert answers